As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results